Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer-Reference-Cited by-同舟云学术

Safety and efficacy of toripalimab in advanced gastric cancer: A new clinical trial bringing hope for immunotherapy in gastric cancer

Published:2020-04 Issue:4 Volume:40 Page:194-196
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Qiu Haibo¹^ORCID

Affiliation:

1. Department of Gastric SurgeryState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer MedicineSun Yat‐Sen University Cancer Center Guangzhou Guangdong 510060 P. R. China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12019

Reference15 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

3. Differences in gastric cancer survival between the U.S. and China

4. National trend of gastric cancer mortality in China (2003‐2015): a population‐based study;Gao K;Cancer Communications.,2019

5. Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions;Petrillo A;Cancers.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma;Journal of Gastrointestinal Oncology;2024-06

2. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023);World Journal of Gastroenterology;2023-10-28

3. Initial experience of video-assisted thoracic surgery lobectomy after neoadjuvant chemotherapy plus toripalimab in a patient with locally advanced non-small cell lung cancer: a case report;Journal of Cardiothoracic Surgery;2022-01-16

4. Durable Clinical Response to Immune and Targeted Therapies in an Elderly Man with Synchronous Gastric (HER2+) and Bladder Cancers: Case Report and Literature Review;OncoTargets and Therapy;2021-06

5. Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors;Biomedicine & Pharmacotherapy;2020-09